(HealthDay)—The antiviral drug remdesivir has been one of the few treatments that's seemed to help curb death rates in COVID-19 patients so ill that they need a ventilator.
Aug 21, 2020
0
230
An international team of researchers has found that three commonly used antiviral and antimalarial drugs are effective in vitro at preventing replication of SARS-CoV-2, the virus that causes COVID-19. The work also underscores ...
Mar 24, 2021
0
141
Investigators at the University of Cincinnati are studying whether or not a modified Atkins-type ketogenic diet could help make treatments for a common, but dangerous, type of brain cancer called glioblastoma more effective.
Sep 30, 2019
0
1927
Research has shown that patients who have had emergency heart attack treatment with heart artery stenting—and have significant narrowings in their other untreated arteries—can benefit from additional stenting to help ...
Sep 29, 2019
0
394
If you're over 40, regular exercise may not only keep you fit—it might keep you out of the hospital, too, a large new study suggests.
Feb 20, 2023
0
306
A new research study showed that circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery ...
Jun 4, 2022
0
739
If you have a cold, don't ask your doctor for antibiotics—that's the golden rule. They're for bacterial infections, not viral ones. We're told not only that they won't work, but that by using antibiotics when they aren't ...
Jan 5, 2022
0
36
Treatment of hypothyroidism, which results from an underactive thyroid gland, should be individualized and consideration should be given to alternatives to the first-line therapy, including desiccated thyroid extract and ...
Mar 20, 2021
0
6
A vaccine (DCVax-L), trialed at King's College Hospital and other centers around the world, using patients' immune cells to target brain cancer can extend survival by many months or, in some cases, years, the final unblinded ...
Nov 21, 2022
0
82
A batch of Johnson & Johnson's COVID-19 vaccine failed quality standards and can't be used, the drug giant said Wednesday.
Apr 1, 2021
0
4
